Education
About Us
Working with TipRanks
Follow Us
Kyntra Bio (KYNB)
NASDAQ:KYNB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 29.62M | $ 46.80M | $ 140.73M | $ 235.31M | $ 176.32M |
| Gross Profit | $ 14.06M | $ 42.84M | $ 120.45M | $ -213.88M | $ 167.45M |
| Operating Income | $ -150.42M | $ -322.72M | $ -301.02M | $ -288.53M | $ -191.88M |
| EBITDA | $ -142.43M | $ -305.20M | $ -282.82M | $ -333.72M | $ -164.28M |
| Net Income | $ -47.58M | $ -284.23M | $ -293.65M | $ -290.02M | $ -189.29M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 50.48M | $ 235.59M | $ 422.01M | $ 405.19M | $ 686.54M |
| Total Assets | $ 214.53M | $ 423.53M | $ 610.09M | $ 773.82M | $ 826.84M |
| Total Debt | $ 90.17M | $ 170.46M | $ 89.89M | $ 99.72M | $ 39.76M |
| Net Debt | $ 39.69M | $ 56.77M | $ -65.81M | $ -71.50M | $ -638.63M |
| Total Liabilities | $ 398.16M | $ 585.73M | $ 611.57M | $ 544.71M | $ 385.39M |
| Stockholders' Equity | $ -225.60M | $ -204.17M | $ -21.45M | $ 209.15M | $ 422.18M |
| Cash Flow | |||||
| Free Cash Flow | $ -138.26M | $ -317.54M | $ -184.67M | $ -112.42M | $ 77.61M |
| Operating Cash Flow | $ -138.00M | $ -315.02M | $ -145.93M | $ -82.23M | $ 81.60M |
| Investing Cash Flow | $ 125.99M | $ 153.66M | $ 89.12M | $ -426.97M | $ 452.49M |
| Financing Cash Flow | $ -255.00K | $ 122.75M | $ 46.78M | $ -563.00K | $ 13.34M |
Kyntra Bio Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.